Global Venous Thromboembolism Treatment Market Size To Surge $10.3 Bn Growth By 2030, Exhibit A Cagr Of 6.2%


(MENAFN- GlobeNewsWire - Nasdaq) Houston, TX, Sept. 12, 2023 (GLOBE NEWSWIRE) -- Zion Market Research has published a new research report titled “VenThromboembolism Treatment Market By Product (Upper Pneumatic Compression Sleeves, Lower Pneumatic Compression Sleeves, Permanent Inferior Vena Cava Filters, Retrievable Inferior Vena Cava Filters, Embolectomy Balloon Catheters, PercutaneThrombectomy Devices, Catheter-Directed Thrombolysis (CDT) Devices, Non-Segmented Pneumatic Compression Pumps, Segmented Pneumatic Compression Pumps Without Gradient, And Segmented Pneumatic Compression Pumps With Calibrated Gradient), By Disease Indication (Deep VenThrombosis And Pulmonary Embolism), And By End-User (Hospitals, Ambulatory Surgical Centers, Clinics, And Others), And By Region - Global And Regional Industry Overview, Market Intelligence, Comprehensive Analysis, Historical Data, And Forecasts 2023 – 2030” in its research database.

“According to the latest research study, the demand of global VenThromboembolism Treatment Market size & share in terms of revenue was valued at USD 7.1 billion in 2022 and it is expected to surpass around USD 10.3 billion mark by 2030, growing at a compound annual growth rate (CAGR) of approximately 6.2% during the forecast period 2023 to 2030.”

What is VenThromboembolism Treatment? How big is the VenThromboembolism Treatment Industry?

Report Overview:

The global venthromboembolism treatment market size was evaluated at $7.1 billion in 2022 and is slated to hit $10.3 billion by the end of 2030 with a CAGR of nearly 6.2% between 2023 and 2030.

The medical term for a blood clot that forms in a vein is called a venthromboembolism (VTE for short). After heart attacks and strokes, this condition is the third most common kind of vascular disease that affects between 300,000 and 600,000 people in the United States each year. The most common causes of venthromboembolism are being hospitalised, having surgery, having cancer, or being immobile. Other risk factors include immobility. When the blood flow in the legs changes or slows significantly, this can lead to the development of deep vein thrombosis in the legs. When it comes to women, the use of hormones during pregnancy for the treatment of menopause symptoms, such as oral contraceptives or oestrogen, can also play a significant role in the development of venthromboembolism.

Get a Free Sample PDF of this Research Report for more Insights with a Table of Content, Research Methodology, and Graphs -

(A free sample of this report is available upon request; please contactfor more information.)

Our Free Sample Report Consists of the Following:

  • Introduction, Overview, and in-depth industry analysis are all included in the 2023 updated report.
  • The COVID-19 Pandemic Outbreak Impact Analysis is included in the package
  • About 215+ Pages Research Report (Including Recent Research)
  • Provide detailed chapter-by-chapter guidance on Request
  • Updated Regional Analysis with Graphical Representation of Size, Share, and Trends for the Year 2023
  • Includes Tables and figures have been updated
  • The most recent version of the report includes the Top Market Players, their Business Strategies, Sales Volume, and Revenue Analysis
  • Zion Market Research research methodology

(Please note that the sample of this report has been modified to include the COVID-19 impact study prior to delivery.)

Global VenThromboembolism Treatment Market: Growth Factors

The expansion of the global market would be boosted throughout the forecast period by an increase in the prevalence of chronic diseases.

There are suggestions that are supported by evidence that can assist medical professionals in making clinical decisions regarding the treatment of pulmonary embolism and deep vein thrombosis. This factor has the potential to push the expansion of the global market for venthromboembolism treatment. A further factor that is anticipated to contribute to the expansion of the market worldwide is the growing requirement for treatments that are economical. Inferior vena cava filter adoption rates are expected to rise, which will be beneficial to market trends worldwide. The demand for therapy for venthromboembolism can be prompted by an increase in the prevalence of cancer as well as an uptick in the number of cardiac problems. The size of the global market is expected to expand in the years to come as a direct result of increased public awareness of treatment options for venthromboembolism.

It is anticipated that the introduction of anticoagulant medications by pharmaceutical companies will bolster demand in markets all over the world. An increase in the number of cases of venthromboembolism can be ascribed to factors such as a sedentary lifestyle, excessive alcohol use, and the consumption of a food low in nutritive value. This might pave the way for a significant increase in the demand for treatment of venthromboembolism. Launches of innovative products have always been a driving force behind economic expansion across all industries, and the medical industry is not an exception to this rule. For example, in the first half of 2021, the pharmaceutical company Jansen Pharmaceuticals, Inc., which has its headquarters in Belgium, announced that it had acquired permission from the Food and Drug Administration of the United States (FDA) for its recently introduced medication, which is known as XARELTO® and is intended to treat pulmonary embolism and deep vein thrombosis.

Directly Purchase a copy of the report with TOC @

Report Scope

Report Attribute Details
Market Size in 2022 USD 7.1 billion
Projected Market Size in 2030 USD 10.3 billion
CAGR Growth Rate 6.2% CAGR
Base Year 2022
Forecast Years 2023-2030
Key Market Players Stryker Corporation, Argon Medical Devices, Cardinal Health (Medtronic), Cook Medical, Boston Scientific Corporation, Koninklijke Philips N.V., Arjo, DJO Global., and others.
Key Segment By Product, By Disease Indication, By End-User, and By Region
Major Regions Covered North America, Europe, Asia Pacific, Latin America, and the Middle East &, Africa
Purchase Options Request customized purchase options to meet your research needs. Explore purchase options

VenThromboembolism Treatment Market: Segmentation Analysis

The market for treatments for venthromboembolism is broken down into several submarkets, including product, disease indication, end-user, and region.

Upper pneumatic compression sleeves, lower pneumatic compression sleeves, permanent inferior vena cava filters, retrievable inferior vena cava filters, embolectomy balloon catheters, percutanethrombectomy devices, catheter-directed thrombolysis (CDT) devices, non-segmented pneumatic compression pumps, segmented pneumatic compression pumps without gradient, and segmented pneumatic cuff pumps are the variproduct categories that make up the global venthromboembolism treatment market

In addition, the retrievable inferior vena cava filters segment, which accounted for about 52% of the total revenue generated by the global market in 2022, is anticipated to register the highest CAGR throughout the course of the period being forecasted. Patients who use retrievable inferior vena cava filters are afforded a number of advantages, including improved health, efficiency, the ability to recuperate from the procedure percutaneously, and defence against pulmonary embolism, all of which contribute to the market segment's projected expansion over the next several years.

Deep venthrombosis and pulmonary embolism are the two primary disease indications that drive the segmentation of the deep venthrombosis and pulmonary embolism submarkets within the global venthromboembolism therapy market. It is anticipated that there would be a significant increase in the number of cases of pulmonary embolism over the period in question. The segmental increase is almost entirely attributable to the rise in the prevalence of pulmonary embolisms. In addition, a number of different programmes are going to be implemented in order to foster segmental growth and improve the general public's understanding of pulmonary embolism.

The market for venthromboembolism treatment is divided into hospitals, ambulatory surgery centres, clinics, and other establishments based on the type of patient who would be receiving it. During the time period under consideration, it is anticipated that the healthcare sector would experience exponential growth. An increase in the patient population base as well as an increase in the number of vena cava surgical procedures conducted by surgeons in hospitals are both factors that can be ascribed to the segmental expansion.

The global VenThromboembolism Treatment market is segmented as follows:

By Product

  • Upper Pneumatic Compression Sleeves
  • Lower Pneumatic Compression Sleeves
  • Permanent Inferior Vena Cava Filters
  • Retrievable Inferior Vena Cava Filters
  • Embolectomy Balloon Catheters
  • PercutaneThrombectomy Devices
  • Catheter-Directed Thrombolysis (CDT) Devices
  • Non-Segmented Pneumatic Compression Pumps
  • Segmented Pneumatic Compression Pumps Without Gradient
  • Segmented Pneumatic Compression Pumps With Calibrated Gradient

By Disease Indication

  • Deep VenThrombosis
  • Pulmonary Embolism

By End-User

  • Hospitals
  • Ambulatory Surgical Centers
  • Clinics
  • Others

Browse the full “VenThromboembolism Treatment Market By Product (Upper Pneumatic Compression Sleeves, Lower Pneumatic Compression Sleeves, Permanent Inferior Vena Cava Filters, Retrievable Inferior Vena Cava Filters, Embolectomy Balloon Catheters, PercutaneThrombectomy Devices, Catheter-Directed Thrombolysis (CDT) Devices, Non-Segmented Pneumatic Compression Pumps, Segmented Pneumatic Compression Pumps Without Gradient, And Segmented Pneumatic Compression Pumps With Calibrated Gradient), By Disease Indication (Deep VenThrombosis And Pulmonary Embolism), And By End-User (Hospitals, Ambulatory Surgical Centers, Clinics, And Others), And By Region - Global And Regional Industry Overview, Market Intelligence, Comprehensive Analysis, Historical Data, And Forecasts 2023 – 2030" Report At

Competitive Landscape

Some of the main competitors dominating the global VenThromboembolism Treatment market include -

  • Stryker Corporation
  • Argon Medical Devices
  • Cardinal Health (Medtronic)
  • Cook Medical
  • Boston Scientific Corporation
  • Koninklijke Philips N.V.
  • Arjo
  • DJO Global

Key Insights from Primary Research :

  • According to the analysis shared by our research forecaster, the VenThromboembolism Treatment market is likely to expand at a CAGR of around 6.2% during the forecast period (2023-2030).
  • In terms of revenue, the VenThromboembolism Treatment market size was valued at around US$ 7.1 billion in 2022 and is projected to reach US$ 10.3 billion by 2030.
  • The global venthromboembolism treatment market is anticipated to grow rapidly over the forecast timeline owing to a surge in heart disorders and an increase in the occurrence of cancer.
  • In terms of product, the retrievable inferior vena cava filters segment is slated to register the highest CAGR over the analysis period.
  • Based on the end-user, the hospital segment is set to dominate the end-user segment over the forecast period.
  • Based on the disease indication, the pulmonary embolism segment is anticipated to lead the disease indication segment over the forecast period.
  • Region-wise, the Asia-Pacific venthromboembolism treatment industry is projected to register the fastest CAGR during the assessment timeline.

Have Any Query? Ask Our Experts:

Key questions answered in this report:

  • What is the market size and growth rate forecast for VenThromboembolism Treatment industry?
  • What are the main driving factors propelling the VenThromboembolism Treatment Market forward?
  • What are the leading companies in the VenThromboembolism Treatment Industry?
  • What segments does the VenThromboembolism Treatment Market cover?
  • How can I receive a free copy of the VenThromboembolism Treatment Market sample report and company profiles?

Key Offerings:

  • Market Size & Forecast by Revenue | 2023−2030
  • Market Dynamics – Leading Trends, Growth Drivers, Restraints, and Investment Opportunities
  • Market Segmentation – A detailed analysis By Product, By Disease Indication, By End-User, and By Region
  • Competitive Landscape – Top Key Vendors and Other Prominent Vendors

Request for Customization on this Report as per your requirements -

(We tailor your report to meet your specific research requirements. Inquire with our sales team about customising your report.)

Regional Analysis :

North America is anticipated to maintain its global market leadership position over the expected timeframe

North American venthromboembolism treatment market is expected to dominate the global market earnings due to increased demand for advanced therapy along with well-established healthcare infrastructure. In addition, the increasing prevalence of venthromboembolism promotes local development. The growing occurrence of the disease in the U.S. will contribute notably towards the growth of the market in North America. The presence of key players in the sub-continent is going to play a key role in leveraging the regional market expansion.

The venthromboembolism treatment industry in the Asia-Pacific is expected to grow at a significant rate over forecasting years due to growing demand for cost-effective treatment combined with improving the region's healthcare infrastructure. Increasing spending on healthcare will further promote regional business growth.

By Region

  • North America
    • U.S.
    • Canada
    • Rest of North America
  • Europe
    • France
    • UK
    • Spain
    • Germany
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Rest of Asia Pacific
  • The Middle East & Africa
    • Saudi Arabia
    • South Africa
    • Rest of the Middle East & Africa
  • Latin America
    • Brazil
    • Argentina
    • Rest of Latin America

To know an additional revised 2023 list of market players, request a brochure of the report:

Browse Other Related Research Reports from Zion Market Research:

Smart Energy Market:

Medical Tourism Market:

Agricultural Ventilation Fans Market:

Rare Disease Genetic Testing Market:

Capillary Blood Collection Devices Market:

Pharmaceutical Sterility Testing Market:

Clinical Microbiology Market:

Neuroblastoma Treatment Market:

OTC Orthopedic Braces Market:

Nitrile Butadiene Rubber (NBR) Market:

Agricultural Microbials Market:

UV (Ultraviolet) Coatings Market:

Pharmaceutical Contract Packaging Market:

Electric Wheelchair Market:

Luxury Car Rental Market:

Smart Vent Market:

Business Process As A Service (BPaaS) Market:

Polyolefin Market:

Nylon Market:

Clinical Laboratory Services Market:

About Zion Market Research:

Zion Market Research is a leading market research organization offering industry expertise and scrupulconsulting services to clients for their business development. The reports and services offered by Zion Market Research are used by prestigiacademic institutions, start-ups, and companies globally to measure and understand the changing international and regional business backgrounds.

Our client's/customer's conviction on our solutions and services has pushedin delivering always the best. Our advanced research solutions have helped them in appropriate decision-making and guidance for strategies to expand their business.

Followon LinkedIn:

Followon Twitter:

Followon Facebook:

Followon Pinterest:

Followon YouTube:

Contact Us:

Zion Market Research

USA/Canada Toll Free: 1 (855) 465-4651

Newark: 1 (302) 444-0166

India: +91 7768 006 007, +91 7768 006 008

Skype no: +13479038971, +17187054574

Skype no. United Kingdom: +442032894158

Web:

Blog:

Still, Looking for More Information? OR Want Data for Inclusion in Magazine, Case Study, or Media?

Email Directly Here with Detail Information:




Tags VenThromboembolism Treat VTE Treatment Deep Vein Thrombosis Blood Clot Awareness VTE Prevention Anticoagulants PatientCare Related Links
  • VenThromboembolism Treatment Market
  • Radar System Market Is Expected To Reach USD 30,932 Million
  • Ultrasonic Welding Systems Market Sizing and Growth Analysis, Trends, Challenges & Opportunities | Global Market to Hit $827 Million by 2030
  • Expanded Beam Fiber Optic Connectors Market Report FoOn Landscape | Current And Future Development 2023-2030
  • Global Fuel Cell Humidifier Market Size, Industry Trends, Historical Data, Growth Analysis Forecast to 2030
  • Global Honeycomb Paperboard Market Size, Share, Trends & Industry Growth Analysis Report to 2030
  • Marine Propeller Market
  • Security Analytics Market
  • Machine Safety Market
  • Laboratory Freezers Market
  • Screw Compressor Market
  • MicroalMarket
  • Printing Inks Market
  • Lab Automation Market
  • Clinical Laboratory Services Market
  • Nylon Market
  • Polyolefin Market
  • Business Process As A Service (BPaaS) Market
  • Smart Vent Market
  • Luxury Car Rental Market

MENAFN12092023004107003653ID1107055335


GlobeNewsWire - Nasdaq

Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.